Host mucosal surface components

Host mucosal surface components represent a diverse collection of molecules and structures that form the primary physical and chemical barrier of the body's internal tracts, including the respiratory, gastrointestinal, and urogenital systems (NIH, 2024) [1.2.2]. This complex interface is primarily composed of a mucus layer rich in high-molecular-weight glycoproteins known as mucins (e.g., MUC2, MUC5AC), supplemented by glycans, secretory antibodies like IgA, and various antimicrobial peptides (ResearchGate, 2000) [1.1.1, 1.1.3]. Biologically, these components serve to lubricate tissues, facilitate nutrient exchange, and provide a scaffold for beneficial commensal microbes while shielding the underlying epithelium from pathogens and toxins (NIH, 2021) [1.2.1]. In clinical contexts, the disruption or depletion of these components is a hallmark of diseases such as inflammatory bowel disease, peptic ulcers, and cystic fibrosis, and it often facilitates the entry of viruses and bacteria (ScienceDaily, 2016) [1.3.4]. Therapeutic interventions targeting these components include mucosal protective agents like sucralfate that bind to exposed proteins, mucolytics like N-acetylcysteine that alter mucus rheology, and mucoadhesive polymers used to enhance drug delivery (NIH, 2024) [1.3.1, 1.3.2]. Additionally, certain drugs like misoprostol act by stimulating the endogenous production of these components to restore barrier integrity and prevent infection (YouTube/Dr. Bhanu Prakash, 2024) [1.3.2].

Other names

Mucosal barrierMucus layerGlycocalyxMucosal surfacePre-epithelial barrier

Therapeutic agents interact with host mucosal surface components by forming protective physical barriers, modulating the viscosity and clearance of mucus, or stimulating the secretion of protective factors like bicarbonate and endogenous mucins.